首页> Expert review of hematology> Combining proteasome with cell cycle inhibitors: A dual attack potentially applicable to multiple hematopoietic malignancies

Combining proteasome with cell cycle inhibitors: A dual attack potentially applicable to multiple hematopoietic malignancies

导出原文传递

翻译打印收藏纠错

第一作者： Holkova,B.

作者： Holkova,B. ^[1] ; Grant,S.

作者单位： Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth Health Science ^[1]

关键词 bortezomib CDK inhibitors flavopiridol NF-κB proteosome inhibitors

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert review of hematology

2011年4卷5期

483-486页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Expert review of hematology

2011年4卷5期

483-486页

检索历史清除

Combining proteasome with cell cycle inhibitors: A dual attack potentially applicable to multiple hematopoietic malignancies

Expert review of hematology

相似文献

同项目论文

Expert review of hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combining proteasome with cell cycle inhibitors: A dual attack potentially applicable to multiple hematopoietic malignancies

Expert review of hematology

相似文献

同项目论文

Expert review of hematology

相关期刊

检索历史清除